This page shows you the latest news items in this category. This is page number 20.

Total 21414 results found since Jan 2013.

Addressing an uncertain future with a culture of psychological safety - Robinson ET, Jones C, Brazeau GA.
Faculty, staff, and administrators in our pharmacy colleges and schools work in well-known organizational structures that form the foundations for cultures and subcultures. The importance of promoting a positive culture and subculture is a frequent discuss...
Source: SafetyLit - July 1, 2023 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

The $125 Climate-Friendly Hack That Electrified My Gas Stove
Being a climate correspondent comes with a certain degree of moral conflict. I write about the deleterious impact of fossil fuel emissions, then I fly to Georgia to report on how rising temperatures are impacting outdoor laborers. I extoll the virtues of heat pumps, but my rented apartment is heated by a gas-fed boiler. I can recite meat’s share of global greenhouse gas emissions by rote (14.5%), but every once in a while I’m tempted by filet mignon on a restaurant menu. Giving up cheese is a non-starter. [time-brightcove not-tgx=”true”] I do choose the sustainable option when I can: When I moved to...
Source: TIME: Health - June 30, 2023 Category: Consumer Health News Authors: Aryn Baker Tags: Uncategorized adaptation climate climate change Climate Is Everything healthscienceclimate Source Type: news

Ozempic and other weight-loss drugs boost pharmacy sales at Rite Aid
Rite Aid Corp. said Thursday that its fiscal first-quarter pharmacy sales got a boost from a new class of drug. Pharmacy sales, which rose 3.4% from a year ago, were boosted by higher sales of Ozempic and other GLP-1 receptor agonists, which are used to treat Type 2 diabetes and obesity. The…#riteaidcorp #glp1
Source: Reuters: Health - June 30, 2023 Category: Consumer Health News Source Type: news

FDA Approves First Gene Therapy for Severe Hemophilia A
FRIDAY, June 30, 2023 -- The U.S. Food and Drug Administration on Thursday approved a costly single-dose gene therapy for patients with severe hemophilia A, a life-threatening hereditary bleeding disorder. The treatment is not cheap: Roctavian will...
Source: Drugs.com - Daily MedNews - June 30, 2023 Category: General Medicine Source Type: news

Merrick Garland ’s Cheap Talk
Attorney General Merrick Garland had a lot to say last week about the Justice Department’s Hunter Biden investigation. But talk is cheap. Mr. Garland has an obligation to prove his assertions of Delaware U.S. Attorney David Weiss ’s authority in that probe. If he can.#merrickgarland #justicedepartment #hunterbiden #delaware #davidweiss
Source: Reuters: Health - June 30, 2023 Category: Consumer Health News Source Type: news

Too Cheap to Ignore: 2 Dividend Stocks Under $10 With at Least 11% Dividend Yield
Every investor seeks to reap the rewards of their stocks; otherwise, they wouldn’t be involved in the markets. However, discovering the ideal investment, one that will yield profits, can prove to be a challenge, particularly in today’s market environment. To ensure solid returns, investors can…#tipranks #greatajax #eps #matthewhowlett #briley #greatajaxs #ajx #strongbuy #reit #piedmontoffice
Source: Reuters: Health - June 30, 2023 Category: Consumer Health News Source Type: news

It ' ll Cost The U.S. Hundreds Of Billions To Reach Its 2030 EV Goal: Report
The clock is ticking, and n o matter how desperate world leaders are to kick the EV transition into full gear, it seems to become more and more clear that there’s still a lot of work to be done before EVs are truly available for everyone. And it definitely won’t be cheap to do it either. We’re not…#automotivenews #departmentofenergy #autonews #level2 #level1
Source: Reuters: Health - June 29, 2023 Category: Consumer Health News Source Type: news

Rite Aid Loss Hits $306 Million As Troubles Mount
Rite Aid reported a quarterly loss of more than $306 million as the drugstore chain grapples with the loss of customers from its pharmacy benefit business.
Source: Forbes.com Healthcare News - June 29, 2023 Category: Pharmaceuticals Authors: Bruce Japsen, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Business /business Retail /retail pharma standard Source Type: news

Walgreens Is Closing 150 Stores; Everyone Should Worry
Closing stores is a fact of life for retailers. But some closings should worry consumers and investors more than others. Take Walgreens Boots Alliance (WBA) - Get Free Report. The pharmacy chain just announced plans to close 150 locations in the United States this year. In its recent third quarter…#wba #rozbrewer #weakerconsumerdemand #targetcorporation #bestbuycompanyinc #bby #macysinc #alotmoreroomtocut #brewer
Source: Reuters: Health - June 29, 2023 Category: Consumer Health News Source Type: news

Wednesday links: hundreds of small decisions
Markets The world has passed gold by. (bloomberg.com) Natural gas prices are wicked cheap. (wsj.com) Why everyone is now betting on a spot Bitcoin ETF. (ft.com) Finance PE firms have a recruiting problem. (institutionalinvestor.com) The European market for IPOs is moribund. (ft.com) Sequoia…#ftcom #finance #sequoiacapital #warnerbrosdiscovery #wbd #tcm #sfeatercom #diplomat
Source: Reuters: Health - June 28, 2023 Category: Consumer Health News Source Type: news

What We Get Wrong About Drugs Like Ozempic
Imagine a new medication was developed that not only provided meaningful improvement for the debilitating chronic condition it’s prescribed, but also helps to treat and prevent a myriad of other serious diseases. Imagine this same drug markedly improved a person’s quality of life with noted reductions in pain and improvements in mobility along with increases in confidence and mood. Now imagine that the media and medical coverage of its release are almost uniformly negative or sensationalistic. This is precisely what has happened with the new generation of anti-obesity medications, that began with Wegovy/Ozempi...
Source: TIME: Health - June 28, 2023 Category: Consumer Health News Authors: Yoni Freedhoff Tags: Uncategorized freelance health Source Type: news

Walgreens slumps in the third quarter; guidance cut and shares fall
It wasn't a good third quarter for Walgreens Boots Alliance Inc. as the pharmacy chain dealt with a "significantly" lower demand for its Covid-related services. Adjusted third-quarter earnings rose slightly to $1 per share from 96 cents per share a year earlier but fell below analysts' expectations of $1.07 per share. The Deerfield, Illinois-based company (Nasdaq: WBA) lowered its 2023 earnings-per-share guidance to $4 –$4.05 from $4.45–$4.65. And its shares were falling more than 9% in Tuesday…
Source: bizjournals.com Health Care:Biotechnology headlines - June 28, 2023 Category: Biotechnology Authors: Ben Miller Source Type: news

NCPDP Creates New Work Group Focused on Innovation and Care...
Healthcare and Pharmacy Stakeholders invited to attend the Work Group Meeting August 2nd, in Spokane, WA(PRWeb June 28, 2023)Read the full story at https://www.prweb.com/releases/ncpdp_creates_new_work_group_focused_on_innovation_and_care_coordination_to_develop_and_enhance_standards_that_support_pharmacist_provided_clinical_services/prweb19417896.htm
Source: PRWeb: Medical Pharmaceuticals - June 28, 2023 Category: Pharmaceuticals Source Type: news

Struggling with a drug crisis, San Francisco wants Narcan available at every pharmacy
San Francisco could become the first city in the country to require every pharmacy within its boundaries to always carry naloxone, a drug that reverses overdoses caused by fentanyl and other opioids
Source: ABC News: Health - June 27, 2023 Category: Consumer Health News Tags: Health Source Type: news

Walgreens slumps in the third quarter; guidance cut and shares fall
It wasn't a good third quarter for Walgreens as the pharmacy chain dealt with a "significantly" lower demand for its Covid-related services.
Source: bizjournals.com Health Care:Biotechnology headlines - June 27, 2023 Category: Biotechnology Authors: Ben Miller Source Type: news